CXCL8 and colorectal cancer: For instance, it can inhibit pyroptosis and the release of interleukin-1β in response to ATP stimulation and bacterial infection (27), and it also reduces Lithocholic Acid-induced Interleukin-8 production in human colorectal cancer cells by inhibiting Src/EGFR and reactive oxygen species (28).